Detalhe da pesquisa
1.
Analysis of schizophrenia-associated genetic markers in the HLA region as risk factors for tardive dyskinesia.
Hum Psychopharmacol
; : e2898, 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38676936
2.
Polygenic risk scores analyses of psychiatric and metabolic traits with antipsychotic-induced weight gain in schizophrenia: an exploratory study.
Pharmacogenomics J
; 23(5): 119-126, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37106021
3.
Review and Consensus on Pharmacogenomic Testing in Psychiatry.
Pharmacopsychiatry
; 54(1): 5-17, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33147643
4.
Schizophrenia-associated gene dysbindin-1 and tardive dyskinesia.
Drug Dev Res
; 82(5): 678-684, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32394511
5.
Influence of Cannabinoid Receptor 1 Genetic Variants on the Subjective Effects of Smoked Cannabis.
Int J Mol Sci
; 22(14)2021 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34299009
6.
Antidepressant-Associated Mania in Bipolar Disorder: A Review and Meta-analysis of Potential Clinical and Genetic Risk Factors.
J Clin Psychopharmacol
; 40(2): 180-185, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32134853
7.
BDNF Val66Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizoaffective disorder patients: a meta-analysis.
Pharmacogenomics J
; 19(3): 269-276, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30181602
8.
Genetic validation study of protein tyrosine phosphatase receptor type D (PTPRD) gene variants and risk for antipsychotic-induced weight gain.
J Neural Transm (Vienna)
; 126(1): 27-33, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30229349
9.
Pharmacogenetic evaluation of a DISP1 gene variant in antidepressant treatment of obsessive-compulsive disorder.
Hum Psychopharmacol
; 33(4): e2659, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29953682
10.
Association study between the neurexin-1 gene and tardive dyskinesia.
Hum Psychopharmacol
; 32(1)2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28120489
11.
Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis.
Int J Neuropsychopharmacol
; 19(5)2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26745992
12.
Association Study of Serotonin 3 Receptor Subunit Gene Variants in Antipsychotic-Induced Weight Gain.
Neuropsychobiology
; 74(3): 169-175, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-28531893
13.
Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapine.
Hum Psychopharmacol
; 31(2): 121-34, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26876050
14.
Association study of GABAA α2 receptor subunit gene variants in antipsychotic-associated weight gain.
J Clin Psychopharmacol
; 35(1): 7-12, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25514066
15.
Genetic variation in CYP3A43 is associated with response to antipsychotic medication.
J Neural Transm (Vienna)
; 122(1): 29-34, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25150845
16.
Association study of GABRG2 polymorphisms with suicidal behaviour in schizophrenia patients with alcohol use disorder.
Neuropsychobiology
; 69(3): 154-8, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24776921
17.
Fat mass- and obesity-associated (FTO) gene and antipsychotic-induced weight gain: an association study.
Neuropsychobiology
; 69(1): 59-63, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24481458
18.
Oligodendrocyte genes, white matter tract integrity, and cognition in schizophrenia.
Cereb Cortex
; 23(9): 2044-57, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22772651
19.
Protein kinase cAMP-dependent regulatory type II beta (PRKAR2B) gene variants in antipsychotic-induced weight gain.
Hum Psychopharmacol
; 29(4): 330-5, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24737441
20.
Heart rate variability: Evaluating a potential biomarker of anxiety disorders.
Psychophysiology
; 61(2): e14481, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37990619